Published in Infect Immun on September 01, 1991
Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. J Clin Microbiol (2003) 2.26
Characterization of Francisella tularensis outer membrane proteins. J Bacteriol (2006) 1.59
Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins. J Bacteriol (1994) 1.48
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man. Immunology (1992) 1.18
Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun (1998) 1.12
Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One (2011) 1.02
Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis. J Clin Microbiol (1992) 1.02
IglG and IglI of the Francisella pathogenicity island are important virulence determinants of Francisella tularensis LVS. Infect Immun (2011) 1.02
Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi. Infect Immun (1993) 0.96
IglE is an outer membrane-associated lipoprotein essential for intracellular survival and murine virulence of type A Francisella tularensis. Infect Immun (2013) 0.96
A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Microb Pathog (2008) 0.90
Identification of disulfide bond isomerase substrates reveals bacterial virulence factors. Mol Microbiol (2014) 0.89
Revisiting the Gram-negative lipoprotein paradigm. J Bacteriol (2015) 0.87
Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Mol Immunol (2009) 0.87
Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets? Front Cell Infect Microbiol (2014) 0.84
An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis. Immunol Res (2009) 0.82
The francisella tularensis proteome and its recognition by antibodies. Front Microbiol (2011) 0.81
Method for the isolation of Francisella tularensis outer membranes. J Vis Exp (2010) 0.81
Lipidation of the FPI protein IglE contributes to Francisella tularensis ssp. novicida intramacrophage replication and virulence. Pathog Dis (2014) 0.81
Novel 33-kilodalton lipoprotein from Mycobacterium leprae. Infect Immun (2002) 0.81
Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei. Antimicrob Agents Chemother (2015) 0.78
Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals. Front Microbiol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol (1951) 28.27
Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem (1981) 26.33
Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim Biophys Acta (1975) 6.25
Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur J Biochem (1973) 5.46
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (1989) 5.08
Biogenesis of lipoproteins in bacteria. Curr Top Microbiol Immunol (1986) 4.23
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun (1990) 4.10
Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114. Infect Immun (1988) 3.42
Mechanism of action of globomycin. J Antibiot (Tokyo) (1978) 2.66
Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect Immun (1982) 2.48
Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. Proc Natl Acad Sci U S A (1982) 2.40
Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions. Infect Immun (1984) 2.37
A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun (1988) 2.34
Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect Immun (1989) 2.15
Characterization of new membrane lipoproteins and their precursors of Escherichia coli. J Biol Chem (1981) 1.94
Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol (1987) 1.64
Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur J Biochem (1987) 1.53
Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect Immun (1983) 1.52
Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis. J Immunol (1990) 1.50
Diversity of Francisella tularensis antigens recognized by human T lymphocytes. Infect Immun (1990) 1.28
A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. J Immunol (1986) 1.13
Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol (1990) 1.08
Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1990) 1.05
Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis. Microb Pathog (1989) 1.00
Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microb Pathog (1989) 0.97
Cyclophosphamide and dimethyl dioctadecyl ammonium bromide immunopotentiate the delayed-type hypersensitivity response to inactivated enveloped viruses. Immunology (1986) 0.79
Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol (1994) 3.37
Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun (1997) 2.40
Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions. Infect Immun (1984) 2.37
A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun (1988) 2.34
Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol (2000) 2.31
Characterization of two unusual clinically significant Francisella strains. J Clin Microbiol (1996) 2.20
Identification of Francisella species and discrimination of type A and type B strains of F. tularensis by 16S rRNA analysis. Appl Environ Microbiol (1990) 2.03
Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol (1997) 1.99
A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis (1993) 1.94
Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect Immun (1996) 1.75
Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol (1985) 1.73
Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol (1987) 1.64
Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.54
A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes. Infect Immun (1984) 1.53
Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect Immun (1983) 1.52
Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis. J Immunol (1990) 1.50
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
Epidemiological analysis of tularemia in Sweden 1931-1993. FEMS Immunol Med Microbiol (1996) 1.46
Superoxide dismutase isozymes in different human tissues, their genetic control and intracellular localization. Hum Hered (1973) 1.45
The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis. Microb Pathog (1992) 1.42
Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1975) 1.42
Cytokine expression in the liver during the early phase of murine tularemia. Infect Immun (1995) 1.39
Isolation of lymphocytes from blood. A procedure combining nylon fibre filtration and differential centrifugation. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.32
Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect Immun (1994) 1.32
Use of RNA hybridization in the diagnosis of a case of ulceroglandular tularemia. Eur J Clin Microbiol Infect Dis (1990) 1.26
Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. Microb Comp Genomics (2000) 1.25
Autolysis of Neisseria gonorrhoeae. Relation between mechanical stability and viability. Br J Vener Dis (1976) 1.22
Inhibition of PHA-induced lymphocyte stimulation by the pregnancy zone protein. FEBS Lett (1973) 1.21
Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection (1992) 1.21
Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man. Immunology (1992) 1.18
Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1978) 1.17
Phagocytosis and virulence of different strains of Porphyromonas gingivalis. Scand J Dent Res (1991) 1.14
Time of lymphocyte response after onset of tularemia and after tularemia vaccination. J Clin Microbiol (1979) 1.14
Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis (1994) 1.13
Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol Med Microbiol (1996) 1.13
Effect of amphotericin B and clotrimazole on lymphocyte stimulation. Antimicrob Agents Chemother (1974) 1.11
Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine. J Clin Microbiol (1985) 1.10
Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J (2000) 1.09
Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol (1990) 1.08
Influence of complement on the chemiluminescent response of human leukocytes to immune complex. Infect Immun (1980) 1.07
Infections with Francisella tularensis biovar palaearctica in hares (Lepus timidus, Lepus europaeus) from Sweden. J Wildl Dis (1988) 1.07
Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine (1999) 1.07
Demonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescence. Infect Immun (1980) 1.05
Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell Death Dis (2011) 1.04
Construction of a shuttle vector for use in Francisella tularensis. FEMS Immunol Med Microbiol (1996) 1.04
Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res (2000) 1.04
Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol Med Microbiol (1996) 1.03
Detection of antigen in urine of a patient with tularemia. Eur J Clin Microbiol (1987) 1.02
Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans. Immunology (1992) 1.00
Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis. Microb Pathog (1989) 1.00
A case of tularemia meningitis in Sweden. Scand J Infect Dis (1990) 0.99
Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol (1998) 0.99
5-fluorocytosine treatment of candida infections of the urinary tract and other sites. Scand J Urol Nephrol (1972) 0.98
Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine (1995) 0.97
Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity. Eur J Oral Sci (2000) 0.97
Inhibition of the mixed lymphocyte reaction by the pregnancy zone protein. FEBS Lett (1975) 0.96
Francisella tularensis: host-parasite interaction. FEMS Immunol Med Microbiol (1996) 0.93
The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin Exp Immunol (2000) 0.92
Comparison of serum and lung extracts for surveys of wild animals for antibodies to Francisella tularensis biovar palaearctica. J Wildl Dis (1988) 0.92
Hospitalization due to Pasteurella multocida-infected animal bite wounds: correlation with inadequate primary antibiotic medication. Scand J Infect Dis (2000) 0.91
Isolation of Francisella tularensis biovar palaearctica from human blood. Eur J Clin Microbiol Infect Dis (1989) 0.89
Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. Res Microbiol (1991) 0.89
Prevalence of antibodies specific to Puumala virus among farmers in Sweden. Scand J Work Environ Health (1998) 0.89
Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis (1997) 0.88
Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis (1993) 0.88
Identification and classification of different isolates of Francisella tularensis. Zentralbl Veterinarmed B (1993) 0.88
Anaerobic phagocytosis, killing, and degradation of Streptococcus pneumoniae by human peripheral blood leukocytes. Infect Immun (1985) 0.88
Ciprofloxacin for treatment of tularemia. Clin Infect Dis (2001) 0.88
Prevalence of serum antibodies to hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins. Scand J Infect Dis (1997) 0.87
Long-lasting recall response of CD4+ and CD8+ alphabeta T cells, but not gammadelta T cells, to heat shock proteins of francisella tularensis. Scand J Infect Dis (2001) 0.87
Anaerobic meningitis in children. Eur J Clin Microbiol (1986) 0.87
Zinc and immune function in Down's syndrome. Acta Paediatr Scand (1980) 0.87
Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome--relation to arterial hypotension and tumor necrosis factor. Infection (1997) 0.86
Detection of nephropathia epidemica virus RNA in patient samples using a nested primer-based polymerase chain reaction. J Infect Dis (1992) 0.86
Wound infections in general surgery. Wound contamination, rates of infection and some consequences. Acta Chir Scand (1976) 0.85